Literature DB >> 20413095

A pathobiont of the microbiota balances host colonization and intestinal inflammation.

Janet Chow1, Sarkis K Mazmanian2.   

Abstract

The gastrointestinal tract harbors a diverse microbiota that has coevolved with mammalian hosts. Though most associations are symbiotic or commensal, some resident bacteria (termed pathobionts) have the potential to cause disease. Bacterial type VI secretion systems (T6SSs) are one mechanism for forging host-microbial interactions. Here we reveal a protective role for the T6SS of Helicobacter hepaticus, a Gram-negative bacterium of the intestinal microbiota. H. hepaticus mutants with a defective T6SS display increased numbers within intestinal epithelial cells (IECs) and during intestinal colonization. Remarkably, the T6SS directs an anti-inflammatory gene expression profile in IECs, and CD4+ T cells from mice colonized with T6SS mutants produce increased interleukin-17 in response to IECs presenting H. hepaticus antigens. Thus, the H. hepaticus T6SS limits colonization and intestinal inflammation, promoting a balanced relationship with the host. We propose that disruption of such balances contributes to human disorders such as inflammatory bowel disease and colon cancer. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20413095      PMCID: PMC2859213          DOI: 10.1016/j.chom.2010.03.004

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  43 in total

Review 1.  Commensal host-bacterial relationships in the gut.

Authors:  L V Hooper; J I Gordon
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

Review 2.  Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases.

Authors:  J V Solnick; D B Schauer
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 3.  The role of the intestinal microbiota in the development of atopic disorders.

Authors:  J Penders; E E Stobberingh; P A van den Brandt; C Thijs
Journal:  Allergy       Date:  2007-08-17       Impact factor: 13.146

Review 4.  The human gut microbiome: implications for future health care.

Authors:  James M Kinross; Alexander C von Roon; Elaine Holmes; Ara Darzi; Jeremy K Nicholson
Journal:  Curr Gastroenterol Rep       Date:  2008-08

5.  Helicobacter hepaticus HHGI1 is a pathogenicity island associated with typhlocolitis in B6.129-IL10 tm1Cgn mice.

Authors:  Zhongming Ge; Torsten Sterzenbach; Mark T Whary; Barry H Rickman; Arlin B Rogers; Zeli Shen; Nancy S Taylor; David B Schauer; Christine Josenhans; Sebastian Suerbaum; James G Fox
Journal:  Microbes Infect       Date:  2008-04-04       Impact factor: 2.700

6.  Molecular characterization of a functional type VI secretion system from a clinical isolate of Aeromonas hydrophila.

Authors:  Giovanni Suarez; Johanna C Sierra; Jian Sha; Shaofei Wang; Tatiana E Erova; Amin A Fadl; Sheri M Foltz; Amy J Horneman; Ashok K Chopra
Journal:  Microb Pathog       Date:  2007-10-24       Impact factor: 3.738

7.  CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven interaction with intestinal epithelial cells independent of local dendritic cells.

Authors:  A M Westendorf; D Fleissner; L Groebe; S Jung; A D Gruber; W Hansen; J Buer
Journal:  Gut       Date:  2008-10-02       Impact factor: 23.059

8.  Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate.

Authors:  Navalpur S Nanda Kumar; Ramadass Balamurugan; Kabirdoss Jayakanthan; Anna Pulimood; Srinivasan Pugazhendhi; Balakrishnan S Ramakrishna
Journal:  J Gastroenterol Hepatol       Date:  2008-12       Impact factor: 4.029

9.  Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice.

Authors:  S E Erdman; V P Rao; T Poutahidis; A B Rogers; C L Taylor; E A Jackson; Z Ge; C W Lee; D B Schauer; G N Wogan; S R Tannenbaum; J G Fox
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

10.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

View more
  105 in total

1.  Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage.

Authors:  Mizuho Hasegawa; Shoko Yada; Meng Zhen Liu; Nobuhiko Kamada; Raúl Muñoz-Planillo; Nhu Do; Gabriel Núñez; Naohiro Inohara
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

Review 2.  Dysbiosis and the immune system.

Authors:  Maayan Levy; Aleksandra A Kolodziejczyk; Christoph A Thaiss; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2017-03-06       Impact factor: 53.106

Review 3.  The potter's wheel: the host's role in sculpting its microbiota.

Authors:  Charles L Bevins; Nita H Salzman
Journal:  Cell Mol Life Sci       Date:  2011-10-04       Impact factor: 9.261

Review 4.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

Review 5.  The immune system and the gut microbiota: friends or foes?

Authors:  Nadine Cerf-Bensussan; Valérie Gaboriau-Routhiau
Journal:  Nat Rev Immunol       Date:  2010-10       Impact factor: 53.106

6.  Characterization of putative virulence genes on the related RepFIB plasmids harbored by Cronobacter spp.

Authors:  A A Franco; L Hu; C J Grim; G Gopinath; V Sathyamoorthy; K G Jarvis; C Lee; J Sadowski; J Kim; M H Kothary; B A McCardell; B D Tall
Journal:  Appl Environ Microbiol       Date:  2011-03-18       Impact factor: 4.792

7.  The Bacteroides fragilis pathogenicity island links virulence and strain competition.

Authors:  Benjamin W Casterline; Aaron L Hecht; Vivian M Choi; Juliane Bubeck Wardenburg
Journal:  Gut Microbes       Date:  2017-02-23

Review 8.  Microbiota modulation of myeloid cells in cancer therapy.

Authors:  Romina S Goldszmid; Amiran Dzutsev; Sophie Viaud; Laurence Zitvogel; Nicholas P Restifo; Giorgio Trinchieri
Journal:  Cancer Immunol Res       Date:  2015-02       Impact factor: 11.151

9.  Elucidation of the Photorhabdus temperata Genome and Generation of a Transposon Mutant Library To Identify Motility Mutants Altered in Pathogenesis.

Authors:  Sheldon Hurst; Holli Rowedder; Brandye Michaels; Hannah Bullock; Ryan Jackobeck; Feseha Abebe-Akele; Umjia Durakovic; Jon Gately; Erik Janicki; Louis S Tisa
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

Review 10.  Microbiota-mediated colonization resistance against intestinal pathogens.

Authors:  Charlie G Buffie; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2013-10-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.